EMN Filing
4Filing Date: May 11, 2026

EASTMAN CHEMICAL CO (EMN) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0000915389-26-000113open_in_new
Total Value$0
Trades2
Insiders1

Transaction Details

OBRIEN JAMES J /KY
Director·Direct
Grant · Acquire
Common Stock
Shares+1.63K
Price$0.00
Total Value$0
Shares Owned After8.46K
Transaction DateMay 7, 2026
Footnotes ▸

Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions related to continued service as a director. The shares amounts represent the director's annual Restricted Stock Award.

OBRIEN JAMES J /KY
Director·Indirect · By Revocable Trust
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After1.02K

Post-Transaction Holdings

OBRIEN JAMES J /KY
SecuritySharesChange
Common Stock9.48K+1.63K (20.74%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-07 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: EASTMAN CHEMICAL CO (EMN) CIK: 0000915389 --- Reporting Owner --- Name: OBRIEN JAMES J /KY CIK: 0001023582 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-07 | Code: A (Grant or award) Shares: +1,628 | Price: $0.00 Shares Owned After: 8,456 | Ownership: D (Direct) Footnotes: [F1] Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions related to continued service as a director. The shares amounts represent the director's annual Restricted Stock Award. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions related to continued service as a director. The shares amounts represent the director's annual Restricted Stock Award. --- Signature --- /s/ /s/ Mark D. Austin, by Power of Attorney for James J. O'Brien (2026-05-11)

keid analysis is for reference only and does not constitute investment advice.